Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03586258 : Neuropsychological and Brain Medical Imaging Study in Patients With Brain Damage 2
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

- Age > 17 years

- French language

- Effective contraception for women during the study

- Informed consent

- No alcohol intake the day before the exam

- For patients only, focal cerebral lesion (stroke, malformation, tumor, inflammatory,
infectious, traumatic), neonatal pathology, developmental or degenerative disease with
cognitive deficit

Exclusion Criteria:

- For healthy volunteers: previous neurological history (except non complicated migraine
or epilepsy), previous psychiatric history (except depression with good evolution or
anxiety), or severe cranial traumatism

- For patients: vigilance disorders, severe depression or anxiety.

- For both: psychotropic medication other than a hypnotic or an anxiolytic at low doses
without dose modification for at least one month, severe visual or auditory
impairment, patient without judicial or administrative liberty, measure of legal
protection or no capable to express their consent, pregnancy or breastfeeding,
contraindication for MRI or GVS if applicable, participation in another trial or
former involvement in another trial within one month.
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557